Roivant Sciences Ltd
ROIV · NASDAQ
Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch "Vants" - nimble and focused biopharmaceutical and health technology companies
ESG Scores
Overall ESG4.8
Environmental4.1
Social2.1
Governance6.6
Gender Diversity
Female Directors0.25%
CEO GenderMale
Market Data
Price$29.53+0.83 (+2.89%)
Market Cap$21.24B
P/E Ratio—
EPS$—
52W High$32.79
52W Low$10.71
Beta1.14